{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:19:30Z","timestamp":1785223170970,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer US","isbn-type":[{"value":"9781071631621","type":"print"},{"value":"9781071631638","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3163-8_12","type":"book-chapter","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T10:07:13Z","timestamp":1684231633000},"page":"171-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mass Spectrometry-Based Tissue Imaging of the Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Tyler","family":"Risom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Rost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Ziai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"12_CR1","doi-asserted-by":"crossref","unstructured":"Eng J, Thibault G, Luoh SW et al (2055) Cyclic Multiplexed-Immunofluorescence (cmIF), a highly multiplexed method for single-cell analysis. Methods Mol Biol 2020:521\u2013562","DOI":"10.1007\/978-1-4939-9773-2_24"},{"issue":"4","key":"12_CR2","first-page":"968","volume":"74","author":"Y Golstev","year":"2018","unstructured":"Golstev Y, Samusik N, Kennedy-Darling J et al (2018) Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell 74(4):968\u2013981","journal-title":"Cell"},{"key":"12_CR3","doi-asserted-by":"publisher","unstructured":"Radtke A, Postolova E, Varlamova A et al (2022) A multi-scale, multiomic atlas of human normal and follicular lymphoma lymph nodes. Biorxiv. https:\/\/doi.org\/10.1101\/2022.06.03.494716","DOI":"10.1101\/2022.06.03.494716"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1021\/ac101901x","volume":"82","author":"D Majonis","year":"2010","unstructured":"Majonis D, Herrera I, Ornatsky O et al (2010) Synthesis of a functional metal-chelating polymer and steps toward quantitative mass cytometry bioassays. Anal Chem 82:8961\u20138969","journal-title":"Anal Chem"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M et al (2018) FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med 379:2395\u20132406","journal-title":"N Engl J Med"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1200\/JCO.20.02232","volume":"39","author":"JR Hecht","year":"2021","unstructured":"Hecht JR, Lonardi S, Bendell J et al (2021) Randomized phase III study of FOLFOX alone and with pegilodecakin as second-line therapy in patients with metastatic pancreatic cancer (SEQUOIA). J Clin Oncol 39:1108\u20131118","journal-title":"J Clin Oncol"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.annonc.2021.01.070","volume":"32","author":"M Tempero","year":"2021","unstructured":"Tempero M, Oh DY, Tabernero J et al (2021) Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study. Ann Oncol 32:600\u2013608","journal-title":"Ann Oncol"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1200\/JCO.20.00590","volume":"38","author":"E Van Cutsem","year":"2020","unstructured":"Van Cutsem E, Tempero MA, Sigal D et al (2020) Randomized phase III trial of pegvorhyaluronidase \u03b1 with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma. J Clin Oncol 38:3185\u20133194","journal-title":"J Clin Oncol"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1053\/j.gastro.2018.12.038","volume":"156","author":"VP Balachandran","year":"2019","unstructured":"Balachandran VP, Beatty GL, Dougan SK (2019) Broadening the impact of immunotherapy to pancreatic cancer: challenges and opportunities. Gastroenterology 156:2056\u20132072","journal-title":"Gastroenterology"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN et al (2017) Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357:409\u2013413","journal-title":"Science"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","volume":"33","author":"RE Royal","year":"2010","unstructured":"Royal RE, Levy C, Turner K et al (2010) Phase 2 trial of single agent ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. J Immunother 33:828\u2013833","journal-title":"J Immunother"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI36183","volume":"119","author":"M Zeisberg","year":"2009","unstructured":"Zeisberg M, Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:1429\u20131437","journal-title":"J Clin Invest"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"15095","DOI":"10.1038\/ncomms15095","volume":"8","author":"JL Carstens","year":"2017","unstructured":"Carstens JL, Correa de Sampaio P, Yang D et al (2017) Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer. Nat Commun 8:15095","journal-title":"Nat Commun"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-17-0162","volume":"23","author":"ES Knudsen","year":"2017","unstructured":"Knudsen ES, Vail P, Balaji U et al (2017) Stratification of pancreatic ductal adenocarcinoma: combinatorial genetic, stromal, and immunologic markers. Clin Cancer Res 23:4429\u20134440","journal-title":"Clin Cancer Res"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/1078-0432.CCR-20-3141","volume":"27","author":"SA V\u00e4yrynen","year":"2021","unstructured":"V\u00e4yrynen SA, Zhang J, Yuan C et al (2021) Composition, spatial characteristics, and prognostic significance of myeloid cell infiltration in pancreatic cancer. Clin Cancer Res 27:1069\u20131081","journal-title":"Clin Cancer Res"},{"issue":"19","key":"12_CR16","doi-asserted-by":"publisher","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","volume":"67","author":"CE Clark","year":"2007","unstructured":"Clark CE, Hingorani SR, Mick R et al (2007) Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 67(19):9518\u20139527","journal-title":"Cancer Res"},{"issue":"21","key":"12_CR17","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1038\/onc.2016.458","volume":"36","author":"X Wang","year":"2017","unstructured":"Wang X, Lang M, Zhao T et al (2017) Cancer-FOXP3 directly activated CCL5 to recruit FOXP3(+)Treg cells in pancreatic ductal adenocarcinoma. Oncogene 36(21):3048\u20133058","journal-title":"Oncogene"}],"container-title":["Methods in Molecular Biology","Cancer Systems and Integrative Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3163-8_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T10:08:38Z","timestamp":1684231718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3163-8_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071631621","9781071631638"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3163-8_12","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"17 May 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}